As of 2024-12-14, the Relative Valuation of Apyx Medical Corp (APYX) is (26.02) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.68 USD, the upside of Apyx Medical Corp based on Relative Valuation is -1648.8%.
The range of the Relative Valuation is (25.93) - (27.57) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 37.0x - 41.3x | 38.8x |
| Forward P/E multiples | 32.4x - 39.3x | 35.4x |
| Fair Price | (25.93) - (27.57) | (26.02) |
| Upside | -1643.6% - -1741.2% | -1648.8% |
| Date | P/E |
| 2024-12-13 | -2.40 |
| 2024-12-12 | -2.41 |
| 2024-12-11 | -2.64 |
| 2024-12-10 | -2.63 |
| 2024-12-09 | -2.34 |
| 2024-12-06 | -2.28 |
| 2024-12-05 | -2.17 |
| 2024-12-04 | -2.21 |
| 2024-12-03 | -2.35 |
| 2024-12-02 | -2.71 |
| 2024-11-29 | -2.30 |
| 2024-11-27 | -2.41 |
| 2024-11-26 | -2.07 |
| 2024-11-25 | -2.05 |
| 2024-11-22 | -2.06 |
| 2024-11-21 | -2.03 |
| 2024-11-20 | -2.00 |
| 2024-11-19 | -1.83 |
| 2024-11-18 | -1.75 |
| 2024-11-15 | -1.80 |
| 2024-11-14 | -1.84 |
| 2024-11-13 | -1.91 |
| 2024-11-12 | -1.95 |
| 2024-11-11 | -2.11 |
| 2024-11-08 | -2.17 |
| 2024-11-07 | -1.74 |
| 2024-11-06 | -1.73 |
| 2024-11-05 | -1.67 |
| 2024-11-04 | -1.66 |
| 2024-11-01 | -1.70 |
| 2024-10-31 | -1.67 |
| 2024-10-30 | -1.75 |
| 2024-10-29 | -1.78 |
| 2024-10-28 | -1.81 |
| 2024-10-25 | -1.73 |
| 2024-10-24 | -1.57 |
| 2024-10-23 | -1.58 |
| 2024-10-22 | -1.63 |
| 2024-10-21 | -1.67 |
| 2024-10-18 | -1.69 |
| 2024-10-17 | -1.70 |
| 2024-10-16 | -1.75 |
| 2024-10-15 | -1.68 |
| 2024-10-14 | -1.66 |
| 2024-10-11 | -1.68 |
| 2024-10-10 | -1.71 |
| 2024-10-09 | -1.70 |
| 2024-10-08 | -1.74 |
| 2024-10-07 | -1.81 |
| 2024-10-04 | -1.82 |